Physician

Alex Meilan Lam, MD

According to 2025 Medicare claims, Alex Lam, MD (NPI: 1275624264) practices rheumatology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is INSTITUTE FOR RHEUMATOLOGY & INTEGRATIVE MEDICINE (NPI: 1457442451; TIN: 20-2897801) and primary practice location at 33027-1720.

Lam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 365 traditional Medicare patients, billed 171,968 HCPCS/CPT codes, and received $1,576,034 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,017 prescription claims across 438 beneficiaries totaling $1,804,791 in drug costs, led by Prolia (Denosumab). DME data shows 12 claims. Open Payments data shows 112 records totaling $2,675. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $654,494 and ending at $1,804,791. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	267	114,139	$1,025,333
2016	297	128,425	$1,184,935
2017	418	191,495	$1,401,191
2018	391	198,859	$1,903,218
2019	414	180,023	$1,895,928
2020	337	167,986	$1,771,832
2021	358	160,689	$1,594,106
2022	293	159,800	$1,408,413
2023	315	143,960	$1,233,189
2024	365	171,968	$1,576,034

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	530	3,456	$654,494
2016	689	4,276	$827,589
2017	890	5,513	$1,971,552
2018	893	6,087	$2,713,887
2019	775	5,071	$2,648,027
2020	561	3,924	$2,055,266
2021	519	3,770	$1,798,625
2022	518	3,012	$3,104,416
2023	450	2,256	$1,929,143
2024	438	2,017	$1,804,791

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	23	$1,980
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$197

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	61	431	$109
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	99	99	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	371	$101
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	111	609	$61
J0897	Injection, denosumab, 1 mg	80	7,501	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolia	Denosumab	168	30,240	$295,010
Humira(Cf) Pen	Adalimumab	22	618	$216,766
Enbrel Mini	Etanercept	17	476	$126,531
Cimzia (2 Pack)	Certolizumab Pegol	20	560	$114,876
Orencia	Abatacept/Maltose	20	560	$88,759

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0140	Walker, with trunk support, adjustable or fixed height, any type	Y	N/R	12	$197

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$2,675	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alex Meilan Lam, MD?

Tedicare shows public-source Medicare data for Alex Meilan Lam, MD (NPI 1275624264), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alex Meilan Lam, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alex Meilan Lam, MD?

Alex Meilan Lam, MD is linked to INSTITUTE FOR RHEUMATOLOGY & INTEGRATIVE MEDICINE (billing NPI 1457442451) in the available physician profile data.

Does Alex Meilan Lam, MD have Open Payments data?

Alex Meilan Lam, MD has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.